KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $25,013,000 | +302.1% | 139,106 | +131.8% | 0.04% | +290.0% |
| Q2 2017 | $6,220,000 | +692.4% | 60,000 | +500.0% | 0.01% | +900.0% |
| Q1 2017 | $785,000 | +70.3% | 10,000 | -2.7% | 0.00% | 0.0% |
| Q4 2016 | $461,000 | -87.4% | 10,282 | -84.3% | 0.00% | -83.3% |
| Q3 2016 | $3,658,000 | +254.8% | 65,486 | +217.6% | 0.01% | +200.0% |
| Q2 2016 | $1,031,000 | +16.8% | 20,621 | +7.2% | 0.00% | 0.0% |
| Q1 2016 | $883,000 | -16.4% | 19,230 | +12.3% | 0.00% | 0.0% |
| Q4 2015 | $1,056,000 | +60.2% | 17,130 | +44.8% | 0.00% | +100.0% |
| Q3 2015 | $659,000 | -38.9% | 11,830 | -33.2% | 0.00% | -50.0% |
| Q2 2015 | $1,079,000 | -42.3% | 17,700 | -45.4% | 0.00% | -33.3% |
| Q1 2015 | $1,869,000 | – | 32,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|